Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2015-07-14
- Target Recruit Count
- 30
- Registration Number
- NCT02497118
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
- Conditions
- Neurotoxicity
- Interventions
- Drug: placeboDrug: GMDrug: oxaliplatin-based chemotherapy
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2018-02-05
- Target Recruit Count
- 145
- Registration Number
- NCT02486198
- Locations
- 🇨🇳
TianjinCIH, Tianjin, Tianjin, China
Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife
- Conditions
- Liver Neoplasms
- Interventions
- Radiation: CyberKnife
- First Posted Date
- 2015-02-13
- Last Posted Date
- 2016-10-07
- Target Recruit Count
- 117
- Registration Number
- NCT02363218
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis
- First Posted Date
- 2014-11-27
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 70
- Registration Number
- NCT02303197
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer
- Conditions
- Gastric Cancer
- Interventions
- Procedure: Dissection of the Superior Mesenteric Vein Lymph Node
- First Posted Date
- 2014-10-23
- Last Posted Date
- 2015-12-09
- Target Recruit Count
- 510
- Registration Number
- NCT02272894
- Locations
- 🇨🇳
Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Molecular Phenotype Changes and Personalized Treatment for CRPC
- Conditions
- Hormone Refractory Prostate Cancer
- Interventions
- Drug: DP & Targeted drugsDrug: EP & Targeted drugs
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2014-08-05
- Target Recruit Count
- 150
- Registration Number
- NCT02208583
- Locations
- 🇨🇳
Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- First Posted Date
- 2014-08-04
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 120
- Registration Number
- NCT02207361
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer
- Conditions
- Metastatic Breast Cancer
- Interventions
- Drug: Gemcitabine，Capecitabine
- First Posted Date
- 2014-08-04
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 120
- Registration Number
- NCT02207335
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock
- Conditions
- Abdominal Infection
- Interventions
- Drug: glycopeptide plus carbapenemDrug: Haizheng Li Xing ® plus tazocin ®
- First Posted Date
- 2014-07-16
- Last Posted Date
- 2014-07-16
- Target Recruit Count
- 100
- Registration Number
- NCT02191475
- Locations
- 🇨🇳
TianjinCIH, Tianjin, Tianjin, China
Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer
- Conditions
- Carcinoma Breast Stage IV
- First Posted Date
- 2014-06-11
- Last Posted Date
- 2015-12-22
- Target Recruit Count
- 80
- Registration Number
- NCT02161315
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China